These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35955767)

  • 1. Hydrogen Sulfide and Substance P Levels in Patients with
    Manandhar S; Scott-Thomas A; Harrington M; Sinha P; Pilbrow A; Richards AM; Cameron V; Bhatia M; Chambers ST
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark.
    Richelsen R; Smit J; Schønheyder HC; Laxsen Anru P; Gutiérrez-Gutiérrez B; Rodríguez-Bãno J; Nielsen H
    J Antimicrob Chemother; 2020 Dec; 75(12):3656-3664. PubMed ID: 32862220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control.
    Hansen DS; Gottschau A; Kolmos HJ
    J Hosp Infect; 1998 Feb; 38(2):119-32. PubMed ID: 9522290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of community-onset extended-spectrum β-lactamase Escherichia coli and Klebsiella pneumoniae bacteraemia: an 11-year population-based case-control-control study in Denmark.
    Richelsen R; Smit J; Laxsen Anru P; Schønheyder HC; Nielsen H
    Clin Microbiol Infect; 2021 Jun; 27(6):871-877. PubMed ID: 32781243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia.
    Kuo TH; Yang CY; Lee CH; Hsieh CC; Ko WC; Lee CC
    Medicine (Baltimore); 2017 Jun; 96(26):e7075. PubMed ID: 28658101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
    Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of preoperative urine culture and bacterial species on infection after percutaneous nephrolithotomy for patients with upper urinary tract stones.
    Yang Z; Lin D; Hong Y; Hu M; Cai W; Pan H; Li Q; Lin J; Ye L
    Sci Rep; 2022 Mar; 12(1):4833. PubMed ID: 35318408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospective study.
    Lee CH; Su LH; Chen FJ; Tang YF; Li CC; Chien CC; Liu JW
    Int J Antimicrob Agents; 2015 Dec; 46(6):610-5. PubMed ID: 26387064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
    Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
    Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole-positive strains of Klebsiella pneumoniae producing hydrogen sulfide in iron-agar slants.
    Braunstein H; Tomasulo M
    Am J Clin Pathol; 1976 May; 65(5):702-5. PubMed ID: 16535814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.
    Thom KA; Schweizer ML; Osih RB; McGregor JC; Furuno JP; Perencevich EN; Harris AD
    BMC Infect Dis; 2008 Sep; 8():116. PubMed ID: 18793400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia.
    Lye DC; Wijaya L; Chan J; Teng CP; Leo YS
    Ann Acad Med Singap; 2008 Oct; 37(10):831-4. PubMed ID: 19037516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes.
    Melzer M; Toner R; Lacey S; Bettany E; Rait G
    Postgrad Med J; 2007 Dec; 83(986):773-6. PubMed ID: 18057178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of hydrogen sulfide and substance P in patients with sepsis.
    Gaddam RR; Chambers S; Murdoch D; Shaw G; Bhatia M
    J Infect; 2017 Oct; 75(4):293-300. PubMed ID: 28760413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and microbiologic characteristics of adult patients with recurrent bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Lee CH; Su LH; Chen FJ; Tang YF; Chien CC; Liu JW
    Clin Microbiol Infect; 2015 Dec; 21(12):1105.e1-8. PubMed ID: 26271718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury.
    Zhang H; Hegde A; Ng SW; Adhikari S; Moochhala SM; Bhatia M
    J Immunol; 2007 Sep; 179(6):4153-60. PubMed ID: 17785854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Quirante OF; Cerrato SG; Pardos SL
    Braz J Infect Dis; 2011; 15(4):370-6. PubMed ID: 21861009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins.
    Chen IH; Nicolau DP; Kuti JL
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31533981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.